An open-label, randomized, 2-period crossover study to evaluate the potential pharmacokinetic interaction between multiple doses of ketoconazole and a single dose of SKI-606 [bosutinib] administered orally to healthy subjects

Trial Profile

An open-label, randomized, 2-period crossover study to evaluate the potential pharmacokinetic interaction between multiple doses of ketoconazole and a single dose of SKI-606 [bosutinib] administered orally to healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Dec 2010

At a glance

  • Drugs Bosutinib; Ketoconazole
  • Indications Chronic myeloid leukaemia; Mycoses; Polycystic kidney disease
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 21 Mar 2009 Results presented at ASCPT
    • 11 Sep 2007 Status changed from in progress to completed.
    • 15 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top